CKD-aP: Beyond the Surface
Leonie Kraft, MD
CKD-aP Treatment Tool Kit
Emilio Sanchez, MD, PhD
Kappa-Opioid Settings: Real-World Evidence Insights
Lucio Manenti, MD, PhD
The Patient-Clinician Connection in Managing CKD-aP
James Burton, DM, FRCP
Real-World IgAN: A Case-Based Approach to Maximizing Kidney Preservation
An De Vriese, MD, PhD
Muh Geot Wong, MBBS, PhD
Beyond GDMT: Timely Consideration of Barostim in Heart Failure
Patrick J. McCann, MD
Rajeev Mohan, MD
Current FSGS Treatment Landscape: More Questions Than Answers
Vladimir Tesar
Meghan Sise, MD
FSGS: When Solutions Fall Short
FSGS: Interpretation of Proteinuria Reduction Thresholds
FSGS 360°: From Patient Experience to Precision Medicine
Kenneth Lieberman, MD
Emerging Therapies in Managing Adult and Pediatric Patients With FSGS: Latest Data
Optimizing IgAN Care: Achieving Lower Proteinuria Targets With Combination Therapy
Jonathan Barratt, MD, PhD
Sydney Tang, MBBS, MD
Continuity in Care: Strategies for Managing Growth Hormone Deficiency Through Life’s Stages
Aristides Maniatis, MD
Kari Hosack
Meagan Broeckert
Sam Watson
VNS: Beyond Seizure Control
Raman Sankar, MD, PhD
Scott Aaronson, MD
Optimizing VNS Parameters: Keys to Therapeutic Success
Differentiating Neuromodulation Therapies: VNS, DBS, ECT, TMS